Roquefort Therapeutics says MK cell therapy patent approved in Japan

Roquefort Therapeutics PLC on Monday announced its patent for mesodermal killer, or MK, cell therapy has been approve ...

Subscribe now to see this Premium News article from

Alliance News Professional covers every UK stock in your portfolio. It goes beyond regulatory news and free web services to give your investment decisions an edge over the crowd.

Click for a FREE Trial

• In The Know - Management and analyst comments that go beyond company announcements.
• Flash headlines on all 2,400 London-listed companies before the news hits the open web.
• Broker Ratings - The earliest tip-offs, many before the market opens.
• Economic data and central bank flashes from UK, US and eurozone.
• Taking AIM - Up to the minute market commentary on AIM stocks.
• Over 500 news items per trading day for just £39.60 per month, and cancel at any time.

Try Alliance News FREE for 1 Month

Call us on [phone] to get started.